CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Menu
Begin main content
Home Reports Halcyon Radiotherapy System for Patients Receiving Cancer Treatment: Clinical Effectiveness and Cost-Effectiveness
Back to Reports

Halcyon Radiotherapy System for Patients Receiving Cancer Treatment: Clinical Effectiveness and Cost-Effectiveness

Last updated: December 13, 2018
Project Number: RB1286-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of the Halcyon radiotherapy system for patients receiving cancer treatment?
  2. What is the cost-effectiveness of the Halcyon radiotherapy system for patients receiving cancer treatment?

Key Message

Three non-randomized studies were identified regarding the clinical effectiveness of the Halcyon radiotherapy system for patients receiving cancer treatment. No economic evaluations were identified.

Files

Halcyon Radiotherapy System for Patients Receiving Cancer Treatment: Clinical Effectiveness and Cost-Effectiveness

Rapid Response

Summary of Abstracts

  • Published: December 13, 2018

Related Content